Antikörper-Wirkstoff-Konjugate als Entitäts-übergreifendes, zielgerichtetes Therapieprinzip in der Onkologie
![Tim KAHL | University of Leipzig, Leipzig | Rudolf Boehm Institute of Pharmacology and Toxicology | Research profile Tim KAHL | University of Leipzig, Leipzig | Rudolf Boehm Institute of Pharmacology and Toxicology | Research profile](https://i1.rgstatic.net/ii/profile.image/1020412452425731-1620296695749_Q512/Tim-Kahl.jpg)
Tim KAHL | University of Leipzig, Leipzig | Rudolf Boehm Institute of Pharmacology and Toxicology | Research profile
Achim Prof. Dr. Aigner – Professor – University of Leipzig, Rudolf-Boehm- Institute for Pharmacology and Toxicology | LinkedIn
![Aigner WALTER | Managing Director | Doctor of Innovation economics and HighTech market analysis | Vienna Austria Europe | Research profile Aigner WALTER | Managing Director | Doctor of Innovation economics and HighTech market analysis | Vienna Austria Europe | Research profile](https://i1.rgstatic.net/ii/profile.image/554023048957953-1509100796494_Q512/Aigner-Walter.jpg)